Advent of Cather-based Valve Implantations Coupled with Advanced Healthcare System is Accelerating the Growth of the Embolic Protection Devices Market in Europe

The Europe embolic protection devices market is estimated to record a solid CAGR of 7.7% during the forecast period (2021-2027). With the advent of catheter-based valve implantations and proven safety/efficacy, transcatheter valve replacement procedures have become an alternative treatment option for selected high-risk patients, particularly elderly patients. In Europe, an approximate 39,931 TAVI procedures were performed in 2016, compared to around 10,660 in 2012. Therefore, the uptake of advanced techniques such as TAVR is high in developed countries such as Germany, France, the UK, Italy, and Spain, which is further driving the rising uptake of embolic protection devices to reduce such procedure related complications. 

Browse the full report description of "Europe Embolic Protection Devices Market Size, Share & Trends Analysis Report by Product (Filter Devices and Occlusion Devices), by Application (Cardiovascular & Peripheral and Neurovascular), and by End-user (Ambulatory Surgery Centers, Freestanding CATH Labs, Hospitals, and Specialty Cardiac Centers) Forecast Period (2021-2027)" at https://www.omrglobal.com/industry-reports/europe-embolic-protection-devices-market

Moreover, the healthcare system in the region is advanced, highly regulated, sophisticated, and evolved with a standard reimbursement structure. The increasing expenditure on healthcare is also contributing to the market growth in Europe. For instance, in May 2019, the MedTech Reimbursement Consulting (MRTC) released significant reimbursement criteria for the use of embolic protection devices during percutaneous cardiac procedures such as PCI and TAVI in 11 European countries, including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. Such favorable funding initiatives are fueling the market growth of advanced treatment options such as embolic protection, thereby contributing to the overall embolic protection devices market in Europe.

Market Coverage

• Market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segments Covered- by Product, Application, and End-user
• Countries Covered- UK, Germany, France, Italy, Spain, and Rest of Europe
• Competitive Landscape- Abbott; Boston Scientific Corp.; Cardinal Health, Inc.; and Medtronic plc

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Europe Embolic Protection Devices Market Report Segment

By Product 

• Filter Devices
• Occlusion Devices

By Application

• Cardiovascular & Peripheral
• Neurovascular

By End-user

• Ambulatory Surgery Centers
• Freestanding CATH Labs
• Hospitals
• Specialty Cardiac Centers

Europe Embolic Protection Devices Market Report Segment

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe 

To learn more about this report request a sample copy @  https://www.omrglobal.com/request-sample/europe-embolic-protection-devices-market